Cargando…

Aldosterone defects in infants and young children with hyperkalemia: A single center retrospective study

INTRODUCTION: Hyperkalemia is a rare but severe condition in young children and usually discovered as a result of hemolysis of the blood samples taken. However, patients with defects in either aldosterone biosynthesis or function can also present with hyperkalemia- as well hyponatremia-associated, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xu, Xie, Yanshu, Tang, Jing, Zhong, Jingzi, Zeng, Dan, Lan, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885047/
https://www.ncbi.nlm.nih.gov/pubmed/36726778
http://dx.doi.org/10.3389/fped.2023.1092388
_version_ 1784879845034950656
author Liu, Xu
Xie, Yanshu
Tang, Jing
Zhong, Jingzi
Zeng, Dan
Lan, Dan
author_facet Liu, Xu
Xie, Yanshu
Tang, Jing
Zhong, Jingzi
Zeng, Dan
Lan, Dan
author_sort Liu, Xu
collection PubMed
description INTRODUCTION: Hyperkalemia is a rare but severe condition in young children and usually discovered as a result of hemolysis of the blood samples taken. However, patients with defects in either aldosterone biosynthesis or function can also present with hyperkalemia- as well hyponatremia-associated, and metabolic acidosis. It is a challenge to make an accurate diagnosis of these clinical conditions. We conducted this study to investigate the clinical and genetic features of aldosterone signaling defects associated hyperkalemia in young children. METHOD: A retrospective review was conducted at the pediatric department of the First Affiliated Hospital of Guangxi Medical University from 2012 to 2022. RESULTS: 47 patients with hyperkalemia were enrolled, of which 80.9% (n = 38) were diagnosed with primary hypoaldosteronism, including congenital adrenal hyperplasia due to 21-hydroxylase deficiency (n = 32), isolated hypoaldosteronism (n = 1) due to CYP11B2 gene mutation and Xp21 contiguous gene deletion syndrome (n = 1). Additionally, 4 patients were clinically-diagnosed with primary adrenal insufficiency. Nine patients were confirmed with aldosterone resistance, of which one child was diagnosed with pseudohypoaldosteronism (PHA) type 1 with a mutation in the NR3C2 gene and 3 children were identified with PHA type 2 due to novel mutations in either the CUL3 or KLHL3 genes. Five patients had PHA type 3 because of pathologies of either the urinary or intestinal tracts. CONCLUSIONS: The etiologies of infants with hyperkalemia associated with aldosterone defects were mostly due to primary hypoaldosteronism. An elevated plasma aldosterone level may be a useful biomarker for the diagnosis an aldosterone functional defect in patients presented with hyperkalemia. However, a normal plasma aldosterone level does rule out an aldosterone defect in either its biosynthesis or function, especially in young infants. Molecular genetic analyses can greatly help to clarify the complexity of disorders and can be used to confirm the diagnosis.
format Online
Article
Text
id pubmed-9885047
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98850472023-01-31 Aldosterone defects in infants and young children with hyperkalemia: A single center retrospective study Liu, Xu Xie, Yanshu Tang, Jing Zhong, Jingzi Zeng, Dan Lan, Dan Front Pediatr Pediatrics INTRODUCTION: Hyperkalemia is a rare but severe condition in young children and usually discovered as a result of hemolysis of the blood samples taken. However, patients with defects in either aldosterone biosynthesis or function can also present with hyperkalemia- as well hyponatremia-associated, and metabolic acidosis. It is a challenge to make an accurate diagnosis of these clinical conditions. We conducted this study to investigate the clinical and genetic features of aldosterone signaling defects associated hyperkalemia in young children. METHOD: A retrospective review was conducted at the pediatric department of the First Affiliated Hospital of Guangxi Medical University from 2012 to 2022. RESULTS: 47 patients with hyperkalemia were enrolled, of which 80.9% (n = 38) were diagnosed with primary hypoaldosteronism, including congenital adrenal hyperplasia due to 21-hydroxylase deficiency (n = 32), isolated hypoaldosteronism (n = 1) due to CYP11B2 gene mutation and Xp21 contiguous gene deletion syndrome (n = 1). Additionally, 4 patients were clinically-diagnosed with primary adrenal insufficiency. Nine patients were confirmed with aldosterone resistance, of which one child was diagnosed with pseudohypoaldosteronism (PHA) type 1 with a mutation in the NR3C2 gene and 3 children were identified with PHA type 2 due to novel mutations in either the CUL3 or KLHL3 genes. Five patients had PHA type 3 because of pathologies of either the urinary or intestinal tracts. CONCLUSIONS: The etiologies of infants with hyperkalemia associated with aldosterone defects were mostly due to primary hypoaldosteronism. An elevated plasma aldosterone level may be a useful biomarker for the diagnosis an aldosterone functional defect in patients presented with hyperkalemia. However, a normal plasma aldosterone level does rule out an aldosterone defect in either its biosynthesis or function, especially in young infants. Molecular genetic analyses can greatly help to clarify the complexity of disorders and can be used to confirm the diagnosis. Frontiers Media S.A. 2023-01-16 /pmc/articles/PMC9885047/ /pubmed/36726778 http://dx.doi.org/10.3389/fped.2023.1092388 Text en © 2023 Liu, Xie, Tang, Zhong, Zeng and Lan. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pediatrics
Liu, Xu
Xie, Yanshu
Tang, Jing
Zhong, Jingzi
Zeng, Dan
Lan, Dan
Aldosterone defects in infants and young children with hyperkalemia: A single center retrospective study
title Aldosterone defects in infants and young children with hyperkalemia: A single center retrospective study
title_full Aldosterone defects in infants and young children with hyperkalemia: A single center retrospective study
title_fullStr Aldosterone defects in infants and young children with hyperkalemia: A single center retrospective study
title_full_unstemmed Aldosterone defects in infants and young children with hyperkalemia: A single center retrospective study
title_short Aldosterone defects in infants and young children with hyperkalemia: A single center retrospective study
title_sort aldosterone defects in infants and young children with hyperkalemia: a single center retrospective study
topic Pediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885047/
https://www.ncbi.nlm.nih.gov/pubmed/36726778
http://dx.doi.org/10.3389/fped.2023.1092388
work_keys_str_mv AT liuxu aldosteronedefectsininfantsandyoungchildrenwithhyperkalemiaasinglecenterretrospectivestudy
AT xieyanshu aldosteronedefectsininfantsandyoungchildrenwithhyperkalemiaasinglecenterretrospectivestudy
AT tangjing aldosteronedefectsininfantsandyoungchildrenwithhyperkalemiaasinglecenterretrospectivestudy
AT zhongjingzi aldosteronedefectsininfantsandyoungchildrenwithhyperkalemiaasinglecenterretrospectivestudy
AT zengdan aldosteronedefectsininfantsandyoungchildrenwithhyperkalemiaasinglecenterretrospectivestudy
AT landan aldosteronedefectsininfantsandyoungchildrenwithhyperkalemiaasinglecenterretrospectivestudy